Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2026Journal of Crohn s and Colitis

Real-world evidence on medication patterns in inflammatory bowel disease the first decade after diagnosis

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHeidi Søgaard ChristensenLLLone LarsenCLC Lees

Discussion

Loading...

Member takes

Overview

Population-wide analysis reveals treatment trends in inflammatory bowel disease, indicating changes in medication use over time.

Key Points

  • This research examines long-term medication patterns in inflammatory bowel disease following diagnosis.
  • Analyzed nationwide registers in Denmark from 2003-2023
  • Followed individuals diagnosed with inflammatory bowel disease for up to 10 years
  • Assessed cumulative and yearly use of various medications
  • 10-year cumulative use of immunomodulators and/or advanced therapies was 37.0% for UC and 74.9% for CD
  • 5-ASA is the primary treatment for UC, while advanced therapies dominate for CD
  • Approximately 50% of patients stopped medication by the tenth year after diagnosis

Cite This Study

Christensen et al. (2026) studied this question.

synapsesocial.com/papers/69ba426d4e9516ffd37a2a69https://doi.org/10.1093/ecco-jcc/jjag025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment2021 · 1,100 citations
  2. 2A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk1988 · 5,027 citations
  3. 3Gender Differences in Inflammatory Bowel Disease2020 · 193 citations
  4. 4Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis2022 · 7 citations
  5. 5Management of inflammatory bowel disease in the elderly: A review2023 · 37 citations